Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$27.97

0.06 (0.21%)

12:46
02/17/17
02/17
12:46
02/17/17
12:46

Sarepta call volume above normal and directionally bullish

Bullish option flow detected in Sarepta with 2,530 calls trading, 1.4x expected, and implied vol increasing over 2 points to 78.09%. 3/3 weekly 27 calls and Mar-17 26 puts are the most active options, with total volume in those strikes near 2,200 contracts. The Put/Call Ratio is 0.62. Earnings are expected on February 28th.

  • 23

    Feb

  • 28

    Feb

SRPT Sarepta
$27.97

0.06 (0.21%)

02/01/17
PIPR
02/01/17
NO CHANGE
PIPR
Piper call reveals 'extremely positive' commentary for Spinraza
Piper Jaffray analyst Joshua Schimmer says his call with a pediatric neuromuscular disease specialist yielded "extremely positive" commentary for the adoption of Biogen (BIIB) and Ionis Pharmaceuticals' (IONS) Spinraza. The specialist noted "explosive" growth in the spinal muscular atrophy population based on increased referral rates and return-to-clinic visits in anticipation of Spinraza, Schimmer tells investors in a research note. The analyst notes that the specialist also has interest in AveXis' (AVXS) gene therapy program, which she sees as encouraging and hopes is complementary to Spinraza. Regarding Sarepta's (SRPT) Exondys 51, the pediatric neuromuscular disease specialist said the launch has been slower with "reimbursement hurdles that reflect the less compelling efficacy data and controversial approval process for that product," Schimmer noted.
02/01/17
LEER
02/01/17
NO CHANGE
Target $32
LEER
Market Perform
Reimbursement landscape for Sarepta Exondys51 may be more tenuous, says Leerink
Leerink analyst Joseph Schwartz says his MEDACorp payor survey suggests that the reimbursement landscape for Sarepta's Exondys51 for the treatment of Duchenne Muscular Dystrophy is more tenuous than management indicated recently. Moreover, the analyst continues to see risk to consensus revenue estimates being achieved in 2017 and beyond. He reiterated a Market Perform rating on the stock and lowered his price target on the shares to $32 from $33.
02/13/17
FBCO
02/13/17
NO CHANGE
FBCO
Outperform
Sarepta shares defended at Credit Suisse
02/13/17
FBCO
02/13/17
NO CHANGE
Target $66
FBCO
Outperform
Credit Suisse says Marathon's steriod doesn't compete with Sarepta DMD drug
Credit Suisse analyst Alethia Young said weakness in shares of Sarepta may be due to confusion around the impact of Deflazacort, Marathon's recently approved steroid for use by Duchenne muscular dystrophy patients. However, she notes that all DMD patients are typically on steroids, this drug has been available outside the U.S. and used off label in the U.S. previously, that it is not a competitor to EXONDYS 51 and does not affect the treatment paradigm. Young has an Outperform rating and $66 price target on Sarepta shares.

TODAY'S FREE FLY STORIES

$DJU

DJ Utility Average

08:21
12/14/17
12/14
08:21
12/14/17
08:21
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:21
12/14/17
12/14
08:21
12/14/17
08:21
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEMG

SemGroup

$27.35

0.2 (0.74%)

08:21
12/14/17
12/14
08:21
12/14/17
08:21
Upgrade
SemGroup rating change  »

SemGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$187.87

0.54 (0.29%)

08:20
12/14/17
12/14
08:20
12/14/17
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$64.15

0.02 (0.03%)

08:20
12/14/17
12/14
08:20
12/14/17
08:20
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$69.49

-0.1 (-0.14%)

08:20
12/14/17
12/14
08:20
12/14/17
08:20
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$97.58

0.08 (0.08%)

08:20
12/14/17
12/14
08:20
12/14/17
08:20
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$15.70

-0.82 (-4.96%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Hot Stocks
Breaking Hot Stocks news story on Teva »

Teva says plans to pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

FB

Facebook

$178.30

1.34 (0.76%)

, GOOG

Alphabet

$1,040.61

0.13 (0.01%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Periodicals
MP criticizes Facebook after claims Russia spent just $1 on brexit ads, BI says »

Facebook (FB) has claimed…

FB

Facebook

$178.30

1.34 (0.76%)

GOOG

Alphabet

$1,040.61

0.13 (0.01%)

GOOGL

Alphabet Class A

$1,051.39

2.62 (0.25%)

TWTR

Twitter

$21.66

0.01 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

  • 07

    Feb

  • 18

    Mar

XLB

S&P Select Materials SPDR

$59.68

0.16 (0.27%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIOD

Diodes

$27.25

-0.32 (-1.16%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Upgrade
Diodes rating change  »

Diodes upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

XLU

Utilities SPDR

$55.40

0.15 (0.27%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$107.61

0.18 (0.17%)

, FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Periodicals
Disney to pay $2.5B break up fee if 21st Century Fox deal stopped by regulators 

Reported by CNBC.

DIS

Disney

$107.61

0.18 (0.17%)

FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

XLP

Consumer Staples Sector SPDR

$56.91

0.32 (0.57%)

08:19
12/14/17
12/14
08:19
12/14/17
08:19
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$83.98

0.29 (0.35%)

08:18
12/14/17
12/14
08:18
12/14/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$151.78

0.9 (0.60%)

08:18
12/14/17
12/14
08:18
12/14/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$246.30

0.86 (0.35%)

08:18
12/14/17
12/14
08:18
12/14/17
08:18
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMC

Vulcan Materials

$123.11

1.6 (1.32%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Recommendations
Vulcan Materials analyst commentary  »

Vulcan Materials backlog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$266.75

-0.03 (-0.01%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$107.61

0.18 (0.17%)

, FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Hot Stocks
Breaking Hot Stocks news story on Disney, 21st Century Fox, 21st Century Fox »

Disney expects 21st…

DIS

Disney

$107.61

0.18 (0.17%)

FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

LUV

Southwest

$63.14

-0.29 (-0.46%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Upgrade
Southwest rating change  »

Southwest upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

XLF

Financial Select Sector

$27.87

-0.35 (-1.24%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$37.34

-0.21 (-0.56%)

, PF

Pinnacle Foods

$56.21

-0.49 (-0.86%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Upgrade
Conagra Brands, Pinnacle Foods rating change  »

Conagra Brands upgraded…

CAG

Conagra Brands

$37.34

-0.21 (-0.56%)

PF

Pinnacle Foods

$56.21

-0.49 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

SMH

Market Vectors Semiconductor

$97.69

0.06 (0.06%)

08:17
12/14/17
12/14
08:17
12/14/17
08:17
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

PowerShares QQQ Trust

$155.99

0.3 (0.19%)

08:16
12/14/17
12/14
08:16
12/14/17
08:16
Technical Analysis
PowerShares QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.